What can you do to protect the newborn brain?

Current Opinion in Anaesthesiology

Volumn 28, Issue 3, 2015, Pages 261-266

  Shea, Katherine Louise ^a   Palanisamy, Arvind ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

fetus; hypothermia; hypoxic ischemic encephalopathy; magnesium; neuroprotection

Indexed keywords

ALLOPURINOL; ERYTHROPOIETIN; INERT GAS; MAGNESIUM; MAGNESIUM SULFATE; MELATONIN; NEUROPROTECTIVE AGENT;

ADJUVANT THERAPY; DELAYED CORD CLAMPING; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; NEUROPROTECTION; OBSTETRIC PROCEDURE; POSTNATAL CARE; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; ADULT; BRAIN; FEMALE; FETAL HYPOXIA; HYPOXIA-ISCHEMIA, BRAIN; NEWBORN; PHYSIOLOGY; PREGNANCY;

ADULT; BRAIN; FEMALE; FETAL HYPOXIA; HUMANS; HYPOTHERMIA, INDUCED; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; NEUROPROTECTIVE AGENTS; PREGNANCY;

EID: 84929994405     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0000000000000184     Document Type: Review

References (50)

1. McIntyre S, Taitz D, Keogh J, et al. A systematic review of risk factors for cerebral palsy in children born at term in developed countries. Dev Med Child Neurol 2013; 55:499-508.
2. Kurinczuk JJ, White-Koning M, Badawi N. Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86:329-338.
3. Yager JY, Armstrong EA, Black AM. Treatment of the term newborn with brain injury: simplicity as the mother of invention. Pediatr Neurol 2009; 40:237-243.
4. Volpe JJ. Perinatal brain injury: from pathogenesis to neuroprotection. Ment Retard Dev Disabil Res Rev 2001; 7:56-64.
5. Low JA. Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004; 30:276-286.
6. Vannucci SJ, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 2004; 207:3149-3154.
7. Johnston MV, Fatemi A, Wilson MA, Northington F. Treatment advances in neonatal neuroprotection and neurointensive care. Lancet Neurol 2011; 10:372-382.
8. Mason BA, Standley CA, Whitty JE, Cotton DB. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate therapy for preeclampsia. Am J Obstet Gynecol 1996; 175:213-217.
9. Chang JJ, Mack WJ, Saver JL, Sanossian N. Magnesium: potential roles in neurovascular disease. Front Neurol 2014; 5:52.
10. Jacquemyn Y, Zecic A, Van Laere D, Roelens K. The use of intravenous magnesium in nonpreeclamptic pregnant women: fetal/neonatal neuroprotection. Arch Gynecol Obstet 2014. (in press).
11. McPherson JA, Rouse DJ, Grobman WA, et al. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes. Obstet Gynecol 2014; 124:749-755.
12. De Jesus LC, Sood BG, Shankaran S, et al. Antenatal magnesium sulfate exposure and acute cardiorespiratory events in preterm infants. Am J Obstet Gynecol 2015; 212:94; e91-e97.
13. Kaandorp JJ, van Bel F, Veen S, et al. Long-term neuroprotective effects of allopurinol after moderate perinatal asphyxia: follow-up of two randomised controlled trials. Arch Dis Child Fetal Neonatal Ed 2012; 97:F162-F166.
14. Kaandorp JJ, van den Broek MP, Benders MJ, et al. Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour. Arch Dis Child Fetal Neonatal Ed 2014; 99:F144-F148.
15. Kaandorp JJ, Benders MJ, Schuit E, et al. Maternal allopurinol administration during suspected fetal hypoxia: a novel neuroprotective intervention? A multicentre randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed 2014.
16. Kane AD, Hansell JA, Herrera EA, et al. Xanthine oxidase and the fetal cardiovascular defence to hypoxia in late gestation ovine pregnancy. J Physiol 2014; 592:475-489.
17. Salmeen KE, Jelin AC, Thiet MP. Perinatal neuroprotection. F1000Prime Rep 2014; 6:6.
18. Elimian A, Goodman J, Escobedo M, et al. Immediate compared with delayed cord clamping in the preterm neonate: a randomized controlled trial. Obstet Gynecol 2014; 124:1075-1079.
19. Andersson O, Domellof M, Andersson D, Hellstrom-Westas L. Effect of delayed vs early umbilical cord clamping on iron status and neurodevelopment at age 12 months: a randomized clinical trial. JAMA Pediatr 2014; 168:547-554.
20. Azzopardi DV, Strohm B, Edwards AD, et al. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009; 361:1349-1358.
21. Azzopardi D, Strohm B, Marlow N, et al. Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med 2014; 371:140-149.
22. Gluckman PD, Wyatt JS, Azzopardi D, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 2005; 365:663-670.
23. Shankaran S, Laptook AR, Ehrenkranz RA, et al. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 2005; 353:1574-1584; This is a landmark trial that confirmed the efficacy of whole body hypothermia for neonatal neuroprotection.
24. Jacobs SE, Berg M, Hunt R, et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst Rev 2013; 1:CD003311.
25. Shankaran S, Laptook AR, Pappas A, et al. Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy: a randomized clinical trial. JAMA 2014; 312:2629-2639.
26. Osredkar D, Thoresen M, Maes E, et al. Hypothermia is not neuroprotective after infection-sensitized neonatal hypoxic-ischemic brain injury. Resuscitation 2014; 85:567-572.
27. Alonso-Alconada D, Alvarez A, Arteaga O, et al. Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia. Int J Mol Sci 2013; 14:9379-9395.
28. Carloni S, Perrone S, Buonocore G, et al. Melatonin protects from the longterm consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008; 44:157-164.
29. Robertson NJ, Faulkner S, Fleiss B, et al. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 2013; 136:90-105.
30. Aly H, Elmahdy H, El-Dib M, et al. Melatonin use for neuroprotection in perinatal asphyxia: a randomized controlled pilot study. J Perinatol 2015; 35:186-191.
31. Merchant NM, Azzopardi DV, Hawwa AF, et al. Pharmacokinetics of melatonin in preterm infants. Br J Clin Pharmacol 2013; 76:725-733.
32. Marti HH. Erythropoietin and the hypoxic brain. J Exp Biol 2004; 207:3233-3242; This is an excellent review of the role of erythropoietin in brain repair.
33. Rangarajan V, Juul SE. Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol 2014; 51:481-488.
34. Marti HH, Bernaudin M, Petit E, Bauer C. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol Sci 2000; 15:225-229.
35. Traudt CM, McPherson RJ, Bauer LA, et al. Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci 2013; 35:491-503.
36. Wu YW, Bauer LA, Ballard RA, et al. Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012; 130:683-691; This study establishes the safety profile and dose range for erythropoeitin therapy in neonates.
37. Rogers EE, Bonifacio SL, Glass HC, et al. Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy. Pediatr Neurol 2014; 51:657-662.
38. Comi AM, Cho E, Mulholland JD, et al. Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol 2008; 38:86-92.
39. Paula S, Greggio S, DaCosta JC. Use of stem cells in perinatal asphyxia: from bench to bedside. J Pediatr (Rio J) 2010; 86:451-464.
40. Gonzales-Portillo GS, Reyes S, Aguirre D, et al. Stem cell therapy for neonatal hypoxic-ischemic encephalopathy. Front Neurol 2014; 5:147.
41. Pimentel-Coelho PM, Mendez-Otero R. Cell therapy for neonatal hypoxicischemic encephalopathy. Stem Cells Dev 2010; 19:299-310.
42. van Velthoven CT, Gonzalez F, Vexler ZS, Ferriero DM. Stem cells for neonatal stroke-the future is here. Front Cell Neurosci 2014; 8:207.
43. Cotten CM, Murtha AP, Goldberg RN, et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J Pediatr 2014; 164:973-979; e971.
44. Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460:232-236.
45. Zhuang L, Yang T, Zhao H, et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012; 40:1724-1730.
46. Lobo N, Yang B, Rizvi M, Ma D. Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy? J Neurosci Res 2013; 91:473-478.
47. Dingley J, Tooley J, Liu X, et al. Xenon ventilation during therapeutic hypothermia in neonatal encephalopathy: a feasibility study. Pediatrics 2014; 133:809-818.
48. Loetscher PD, Rossaint J, Rossaint R, et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009; 13:R206.
49. Tagin M, Shah PS, Lee KS. Magnesium for newborns with hypoxic-ischemic encephalopathy: a systematic review and meta-analysis. J Perinatol 2013; 33:663-669.
50. Galinsky R, Bennet L, Groenendaal F, et al. Magnesium is not consistently neuroprotective for perinatal hypoxia-ischemia in term-equivalent models in preclinical studies: a systematic review. Dev Neurosci 2014; 36:73-82.